[Ip-health] Pharmaceutical global R&D was 7.9 percent of sales in 2010

Jamie Love james.love at keionline.org
Thu Jun 9 11:22:54 PDT 2011


http://www.keionline.org/node/1152

Pharmaceutical global R&D was 7.9 percent of sales in 2010

Using industry assertions of R&D spending, pharmaceutical related R&D
spending by the private sector was less than 8 percent of global sales
in 2010.

[Graph: http://keionline.org/sites/default/files/u4/sales_rnd_2010.png]

These are the data:

2010 Global R&D by all private companies: - $67.4 billion
Source: Page 2 of the 2011 PhRMA industry profile
http://www.phrma.org/sites/default/files/159/phrma_profile_2011_final.pdf

2010 Global sales - $856
Source: IMS Health Market Prognosis, March 2011
http://www.imshealth.com/deployedfiles/imshealth/Global/Content/StaticFile/Top_Line_Data/Total_Market_2003-2010.pdf

R&D / Sales = 0.078738318

How much of the 7.9 percent invested in R&D is invested in the
development of new products that are medically important? Given the
small number of FDA priority NCE approvals, that number is
significantly lower.

-- 
James Love.  Knowledge Ecology International
http://www.keionline.org, +1.202.332.2670, US Mobile: +1.202.361.3040,
Geneva Mobile: +41.76.413.6584, efax: +1.888.245.3140.
twitter.com/jamie_love




More information about the Ip-health mailing list